Scientific Research and Essays

  • Abbreviation: Sci. Res. Essays
  • Language: English
  • ISSN: 1992-2248
  • DOI: 10.5897/SRE
  • Start Year: 2006
  • Published Articles: 2768

Full Length Research Paper

Asphyxial hypoxic preconditioning induces neuroprotective effect via activation of toll-like receptor 4 (TLR4) signal pathway in rats

Yong-Wang Li1, Li Ma2, Bao-Guo Wang3*, Hai-Long Jin4 and Ju-Qiang Han5
  1Department of Anesthesiology, The Second Artillery General Hospital, Beijing 100088, China. 2Department of Gynaecology and Obstetrics, The Second Artillery General Hospital, Beijing 100088, China. 3Department of Anesthesiology, Beijing Sanbo Brain Hospital, Capital Medical University, No. 50, Xiang Shan Yi-ke-song, Haidian District, Beijing 100093, China. 4Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China. 5Basic Medical Sciences Academy of Military Medical Sciences of Chinese PLA, Beijing 100071, China.
Email: [email protected]

  •  Accepted: 09 May 2011
  •  Published: 31 July 2011

Abstract

 

Hypoxic preconditioning (HP) induces neuroprotective effect against cerebral ischemia, but the mechanism still remains unclear. In this study, we investigated whether the toll-like receptor 4 (TLR4) signal pathway was involved in cerebral ischemic tolerance. According to the treatment of HP and asphyxial cardiac arrest (ACA), rats were assigned to ACA group, HP + ACA group, HP group and Sham group. Rat mortality was 5% in HP + ACA group and 30% in ACA group (P<0.01); neurofunctional scores in HP and HP + ACA group were better than in ACA group (P<0.05). Compared with Sham group, TLR4 mRNA expression, NF-кB activity and the production of TNF-α and IL-6 in HP or HP + ACA or ACA group were significantly increased. The increase was progressively significant in groups (AHP < AHP + ACA < ACA) (P<0.01). HP induced mild inflammation via activating the TLR4 signal pathway and then further inhibited inflammatory response induced by ACA.

 

Key words: Asphyxial cardiac arrest, hypoxic preconditioning, cerebral ischemic tolerance, toll-like receptor 4.